News articles for Integrated BioTherapeutics Inc:
Tuesday, February 26, 2013
New Bioterrorism Vaccine Gets First Test In Humans
GAITHERSBURG, Md., Feb. 26, 2013 /PRNewswire/ -- Integrated BioTherapeutics (IBT) announces the initiation of a Phase 1 clinical trial testing the safety and immunogenicity of its staphylococcal enterotoxin B vaccine "STEBVAX" in healthy adults.
This trial, marking the first time a superantigen vaccine has been administered ... read more